DCTH$14.044.10%-0.60
After Hours: 13.85-0.19 -1.35%
Delcath Systems Inc (DCTH)
Date: 2026-10-30 16:00O: 14.64H: 15.24L: 13.91C: 14.04Vol: 427.1k
Delcath Systems Inc stock is traded at $14.04, with a volume of 427,050. It is down -4.10% in the last 24 hours and down -12.09% over the past month. Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
Previous Close:
$14.64
Open:
$14.64
24h Volume:
427,050
Relative Volume:
1.40
Market Cap:
$487.17M
Revenue:
$90.44M
Net Income/Loss:
$561.00K
P/E Ratio:
2,340.00
EPS:
$0.006
Net Cash Flow:
$19.19M
1W Performance:
-2.64%
1M Performance:
-12.09%
6M Performance:
+35.26%
1Y Performance:
+49.36%
1-Day Range:
$13.91$15.24
1-Week Range:
$13.91$15.24
52-Week Range:
$8.12$17.42
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems IncSector
HealthcareIndustry
Medical DevicesPhone
(518) 743-8892Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY, USACompare DCTH vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCTH Delcath Systems Inc | $14.04 | $487.17M | $90.44M | $561.00K | $19.19M | $0.006 |
 ABT Abbott Laboratories | $106.20 | $183.77B | $46.59B | $5.41B | $7.38B | $3.09 |
 MDT Medtronic Plc | $96.54 | $123.49B | $36.36B | $4.84B | $5.43B | $3.73 |
 SYK Stryker Corp | $291.86 | $111.95B | $25.27B | $3.34B | $4.57B | $8.63 |
 BSX Boston Scientific Corp | $41.98 | $60.84B | $20.62B | $3.56B | $3.48B | $2.38 |
 EW Edwards Lifesciences Corp | $92.01 | $53.03B | $6.30B | $1.07B | $1.09B | $1.84 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Delcath Systems Inc Stock (DCTH) Insider Trading
- Sylvester John RichardNov 21 '25Director
- Transaction
- Buy
- Cost
- $8.89
- #Shares
- 4,386
- Value ($)
- 38,992
- #Shares Total
- 14,936
- MICHEL GERARD JNov 11 '25CHIEF EXECUTIVE OFFICER
- Transaction
- Buy
- Cost
- $8.53
- #Shares
- 11,500
- Value ($)
- 98,049
- #Shares Total
- 330,834
